At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MRNY YieldMax MRNA Option Income Strategy ETF
Market Closed 10-09 16:00:00 EDT
43.63
+3.96
+9.98%
盘后43.46
-0.17-0.39%
19:49 EDT
High43.73Low39.63Vol539.82K
Open39.80D1 Closing39.67Amplitude10.34%
Mkt Cap247.82MTradable Cap247.82MTotal Shares5.68M
T/O22.63MT/O Rate9.50%Tradable Shares5.68M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Moderna Has Surged 660% Year-To-Date, Joining The Nasdaq 100 As BofA Raises Its Price Target
Reuters  ·  10-10 10:44
Moderna Has Surged 660% Year-To-Date, Joining The Nasdaq 100 As BofA Raises Its Price Target
Weekly Winners | PTC Soars Over 35%; Moderna Hits New High in More Than Four Years; Energy and SpaceX Partnership Concepts Show Strong Momentum
Tiger Newspress  ·  10-10 20:11
Weekly Winners | PTC Soars Over 35%; Moderna Hits New High in More Than Four Years; Energy and SpaceX Partnership Concepts Show Strong Momentum
Post-Bell｜U.S. Indices Rise; Moderna Surges Over 14%, Palantir Jumps More Than 5% to a Record High, Tesla Rises Over 2%
Tiger Newspress  ·  10-10 07:01
Post-Bell｜U.S. Indices Rise; Moderna Surges Over 14%, Palantir Jumps More Than 5% to a Record High, Tesla Rises Over 2%
Moderna Inc. Stock Advances 14.2%, Outperforms Peers
Dow Jones  ·  10-10 04:32
Moderna Inc. Stock Advances 14.2%, Outperforms Peers
US Equity Markets End Higher Amid Broad Rally, Strong Mega-Cap Gains
MT Newswires Live  ·  10-10 04:22
US Equity Markets End Higher Amid Broad Rally, Strong Mega-Cap Gains
S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT
Reuters  ·  10-10 03:30
S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT
Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why
TIPRANKS  ·  10-10 02:12
Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why
Moderna up over 11%, on Track for Highest Close Since January 2022
Dow Jones  ·  10-10 01:30
Moderna up over 11%, on Track for Highest Close Since January 2022
Sector Update: Healthcare
MT Newswires Live  ·  10-10 01:18
Sector Update: Healthcare
Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.
Dow Jones  ·  10-10 00:31
Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.
Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors
TIPRANKS  ·  10-10 00:30
Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors
Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening
Stock News  ·  10-10 00:28
Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening
Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand
MT Newswires Live  ·  10-10 00:14
Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand
Top Midday Gainers
MT Newswires Live  ·  10-10 00:06
Top Midday Gainers
Moderna Stock Surges Over 10% to Hit New Recent High: Melanoma Vaccine Data Set for ESMO, BofA Raises Price Target to $200
TradingKey  ·  10-09 23:32
Moderna Stock Surges Over 10% to Hit New Recent High: Melanoma Vaccine Data Set for ESMO, BofA Raises Price Target to $200
NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-10-09
Reuters  ·  10-09 23:01
NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-10-09
Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines
MT Newswires Live  ·  10-09 22:57
Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines
NIH Plans to Expedite Cancer Vaccines, NYT Reports; Vaccine Developer Shares Jump
MT Newswires Live  ·  10-09 22:48
NIH Plans to Expedite Cancer Vaccines, NYT Reports; Vaccine Developer Shares Jump
Pharma Stocks Jump With Novavax up 12%, Moderna up 6%
Tiger Newspress  ·  10-09 22:22
Pharma Stocks Jump With Novavax up 12%, Moderna up 6%
BofA Securities Adjusts Price Target on Moderna to $200 From $170, Maintains Neutral Rating
MT Newswires Live  ·  10-09 22:17
BofA Securities Adjusts Price Target on Moderna to $200 From $170, Maintains Neutral Rating

Introduction

Company Name.
YieldMax MRNA Option Income Strategy ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund advisor will seek to employ the fund's investment strategy as the fund relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. The fund is non-diversified.
Issue price:
--